Kelvin Baggett

Kelvin A.
Baggett, M.D.
is a Managing Director on Patient Square Capital’s Transformation and Growth Team, where he serves as the Head of Patient Impact and Chair of Patient Square’s EMPIRIC Institute (Excellence in Medicine, Patient Impact Research, Innovation and Care).
In his leadership role with Patient Square’s EMPIRIC Institute, Dr. Baggett utilizes his extensive health care experience to measure and drive improvements in quality, care delivery, health outcomes, and patient impact on a large scale across Patient Square’s investments.
Prior to joining Patient Square, Kelvin served as the Executive Vice President & Chief Impact Officer at McKesson, a Fortune 10 company.
As a member of McKesson’s Executive Operating Team, he was responsible for global strategies and initiatives and played a pivotal role in shaping McKesson’s purpose of “Advancing Health Outcomes for All.” Before McKesson, Kelvin served as the Chief Operating Officer for Health Care Navigator, the Senior Vice President & Chief Clinical Officer at Tenet Healthcare Corporation, and prior to that as the Chief Operating Officer, Clinical Services Group for HCA Healthcare.
During the COVID-19 pandemic, Kelvin served as a civic volunteer as the City of Dallas’ COVID-19 Health and Healthcare Access Czar.
Kelvin completed his medical training in Internal Medicine at the Yale University School of Medicine.
He completed advanced training as a Robert Wood Johnson Clinical Scholar at the Johns Hopkins University School of Medicine and as a Fellow at the Duke University School of Medicine.
He earned his B.S.
in Biology from the University of North Carolina at Chapel Hill, a Doctor of Medicine Degree from the East Carolina University School of Medicine, a Master of Public Health Degree from the Johns Hopkins Bloomberg School of Public Health, and a Master of Business Administration Degree from the Duke University Fuqua School of Business.